APA (7th ed.) Citation

NE, G., MN, R., L, R., & F, I. (2019). SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: Pathophysiology, clinical outcomes, and future directions. Dove Medical Press.

Chicago Style (17th ed.) Citation

NE, Gharaibeh, Rahhal MN, Rahimi L, and Ismail-Beigi F. SGLT-2 Inhibitors as Promising Therapeutics for Non-alcoholic Fatty Liver Disease: Pathophysiology, Clinical Outcomes, and Future Directions. Dove Medical Press, 2019.

MLA (8th ed.) Citation

NE, Gharaibeh, et al. SGLT-2 Inhibitors as Promising Therapeutics for Non-alcoholic Fatty Liver Disease: Pathophysiology, Clinical Outcomes, and Future Directions. Dove Medical Press, 2019.